Literature DB >> 24763824

Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.

Juliana Inês Santos1, Ana Luísa Teixeira, Francisca Dias, Mónica Gomes, Augusto Nogueira, Joana Assis, Rui Medeiros.   

Abstract

In developed countries, prostate cancer (PC) is the neoplasia more frequently diagnosed in men. The signaling pathway induced by the transforming growth factor β1 (TGFβ1) has an important role in cell growth, differentiation, and development, the downregulation of this pathway being associated with cancer development. In PC, the activation of this signaling pathway is lost, resulting in favoring of tumor growth, proliferation, and evasion of apoptosis. Several studies have shown that microRNAs (miRNAs), small non-coding RNA, are closely associated with the development, invasion, and metastasis, suggesting that they have a critical role in cancer development. Recently, Smad proteins, the signal transducers of the TGFβ1 signaling pathway, were found to regulate miRNA expression, through both transcriptional and posttranscriptional mechanisms. In this review, we summarize the mechanisms underlying Smad-mediated regulation of miRNA biogenesis and the effects on cancer development, particularly in PC. We identify that TGFβ1-related miR-143, miR-145, miR-146a, and miR-199a may have a key role in the development of prostate cancer metastasis and the restoration of their expression may be a promising therapeutic strategy for PC treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24763824     DOI: 10.1007/s13277-014-1887-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  90 in total

1.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

2.  Regulation of TGF-β1 expression by androgen deprivation therapy of prostate cancer.

Authors:  Paolo Fuzio; Pasquale Ditonno; Monica Rutigliano; Michele Battaglia; Carlo Bettocchi; Antonia Loverre; Giuseppe Grandaliano; Elda Perlino
Journal:  Cancer Lett       Date:  2011-10-01       Impact factor: 8.679

3.  Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.

Authors:  Miki Fuse; Nijiro Nohata; Satoko Kojima; Shinichi Sakamoto; Takeshi Chiyomaru; Kazumori Kawakami; Hideki Enokida; Masayuki Nakagawa; Yukio Naya; Tomohiko Ichikawa; Naohiko Seki
Journal:  Int J Oncol       Date:  2011-01-21       Impact factor: 5.650

4.  [Use of [-2] pro PSA and phi index for early detection of prostate cancer: a prospective of 452 patients].

Authors:  A Houlgatte; S Vincendeau; F Desfemmes; J Ramirez; N Benoist; K Bensalah; X Durand
Journal:  Prog Urol       Date:  2011-10-24       Impact factor: 0.915

Review 5.  The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.

Authors:  Manav Korpal; Yibin Kang
Journal:  RNA Biol       Date:  2008 Jul-Sep       Impact factor: 4.652

6.  Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.

Authors:  Yu Yin; Zhi-Ping Yan; Na-Na Lu; Qing Xu; Jun He; Xu Qian; Jing Yu; Xin Guan; Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Biochim Biophys Acta       Date:  2012-11-29

7.  Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.

Authors:  Yoshiro Itatani; Kenji Kawada; Teruaki Fujishita; Fumihiko Kakizaki; Hideyo Hirai; Takuya Matsumoto; Masayoshi Iwamoto; Susumu Inamoto; Etsuro Hatano; Suguru Hasegawa; Taira Maekawa; Shinji Uemoto; Yoshiharu Sakai; Makoto Mark Taketo
Journal:  Gastroenterology       Date:  2013-07-25       Impact factor: 22.682

8.  Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells.

Authors:  Yukihiro Akao; Yoshihito Nakagawa; Akio Iio; Tomoki Naoe
Journal:  Leuk Res       Date:  2009-05-21       Impact factor: 3.156

9.  Castration-resistant prostate cancer: mechanisms, targets, and treatment.

Authors:  Teresa Maria Santos Amaral; Daniela Macedo; Isabel Fernandes; Luis Costa
Journal:  Prostate Cancer       Date:  2012-03-05

Review 10.  The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer.

Authors:  Catherine Labbaye; Ugo Testa
Journal:  J Hematol Oncol       Date:  2012-03-27       Impact factor: 17.388

View more
  11 in total

1.  Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy.

Authors:  Zhonghua Lu; Yiting Tang; Judong Luo; Shuyu Zhang; Xifa Zhou; Lei Fu
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

2.  TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT.

Authors:  Junlong Zhuang; Qun Lu; Bing Shen; Xiaojing Huang; Lan Shen; Xi Zheng; Ruimin Huang; Jun Yan; Hongqian Guo
Journal:  Sci Rep       Date:  2015-07-08       Impact factor: 4.379

3.  MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.

Authors:  Fei Ma; Hongjiang Song; Baoliang Guo; Yuxin Zhang; Yasheng Zheng; Chengchun Lin; Ying Wu; Guijie Guan; Ruihua Sha; Qingxin Zhou; Dejun Wang; Xinglu Zhou; Juan Li; Xiaohui Qiu
Journal:  Oncotarget       Date:  2015-07-10

4.  Exosomes as mediators of platinum resistance in ovarian cancer.

Authors:  Jennifer Crow; Safinur Atay; Samagya Banskota; Brittany Artale; Sarah Schmitt; Andrew K Godwin
Journal:  Oncotarget       Date:  2017-02-14

5.  Role of miR-647 in human gastric cancer suppression.

Authors:  Wenlong Cao; Weiyuan Wei; Zexu Zhan; Dongyi Xie; Yubo Xie; Qiang Xiao
Journal:  Oncol Rep       Date:  2017-01-17       Impact factor: 3.906

6.  Transforming Growth Factor-β1 Selectively Recruits microRNAs to the RNA-Induced Silencing Complex and Degrades CFTR mRNA under Permissive Conditions in Human Bronchial Epithelial Cells.

Authors:  Nilay Mitash; Fangping Mu; Joshua E Donovan; Michael M Myerburg; Sarangarajan Ranganathan; Catherine M Greene; Agnieszka Swiatecka-Urban
Journal:  Int J Mol Sci       Date:  2019-10-05       Impact factor: 5.923

Review 7.  Noncoding RNAs as novel biomarkers in prostate cancer.

Authors:  C G H Rönnau; G W Verhaegh; M V Luna-Velez; J A Schalken
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

Review 8.  Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.

Authors:  Wei Hu; Chongxi Fan; Peng Jiang; Zhiqiang Ma; Xiaolong Yan; Shouyin Di; Shuai Jiang; Tian Li; Yedong Cheng; Yang Yang
Journal:  Oncotarget       Date:  2016-01-05

9.  MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1.

Authors:  Feng Qu; Jinyu Zheng; Weidong Gan; Huibo Lian; Hua He; Wuping Li; Tian Yuan; Yaling Yang; Xiaogong Li; Changwei Ji; Xiang Yan; Linfeng Xu; Hongqian Guo
Journal:  Oncotarget       Date:  2017-04-18

10.  Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng.

Authors:  Behnam Kamalidehghan; Soudeh Ghafouri-Fard; Elahe Motevaseli; Fatemeh Ahmadipour
Journal:  Drug Des Devel Ther       Date:  2018-05-04       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.